Integra Lifesciences Holdings (IART) EBITDA Margin (2009 - 2026)
Integra Lifesciences Holdings recorded quarterly EBITDA Margin of 1.4% in Q1 2026, down 126.39% quarter-over-quarter from 5.3% in Q4 2025, and up 431.0% year-over-year from 0.26% in Q1 2025.
Integra Lifesciences Holdings' EBITDA Margin history runs 18 years deep, the most recent figure standing at 1.4% for Q1 2026.
- In Q1 2026, EBITDA Margin rose 431.0% year-over-year to 1.4%; the TTM figure through Mar 2026 stood at 29.18% (down 2773.0% YoY), while the FY2025 annual figure was 30.17%, down 3194.0% from the prior year.
- EBITDA Margin came in at 1.4% for Q1 2026 at Integra Lifesciences Holdings, down from 5.3% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 17.04% in Q4 2022 to a low of 118.11% in Q2 2025.
- A 5-year average of 2.54% and a median of 4.29% in 2023 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin jumped 585 bps in 2022 and slumped 11321 bps in 2025, its largest moves.
- Integra Lifesciences Holdings' EBITDA Margin stood at 17.04% in 2022, then tumbled by 47 bps to 9.08% in 2023, then fell by 11 bps to 8.05% in 2024, then sank by 34 bps to 5.3% in 2025, then plunged by 126 bps to 1.4% in 2026.
- According to Business Quant data, EBITDA Margin over the past three periods registered 1.4%, 5.3%, and 1.61% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 14.52% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.94% |
| 10 | Integra Lifesciences Holdings | 1.20 Bn | 939.16 Mn | 216.98 Mn | -1.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.40% |
| Dec 31, 2025 | 5.30% |
| Sep 30, 2025 | -1.61% |
| Jun 30, 2025 | -118.11% |
| Mar 31, 2025 | -5.70% |
| Dec 31, 2024 | 8.05% |
| Sep 30, 2024 | -4.42% |
| Jun 30, 2024 | -4.90% |
| Mar 31, 2024 | 0.32% |
| Dec 31, 2023 | 9.08% |
| Sep 30, 2023 | 4.29% |
| Jun 30, 2023 | 0.51% |
| Mar 31, 2023 | 5.52% |
| Dec 31, 2022 | 17.04% |
| Sep 30, 2022 | 14.46% |
| Jun 30, 2022 | 13.22% |
| Mar 31, 2022 | 15.14% |
| Dec 31, 2021 | 14.36% |
| Sep 30, 2021 | 12.00% |
| Jun 30, 2021 | 7.37% |
| Mar 31, 2021 | 21.06% |
| Dec 31, 2020 | 13.55% |
| Sep 30, 2020 | 11.76% |
| Jun 30, 2020 | 0.42% |
| Mar 31, 2020 | -5.36% |
| Dec 31, 2019 | 9.13% |
| Sep 30, 2019 | -12.27% |
| Jun 30, 2019 | 4.62% |
| Mar 31, 2019 | 5.98% |
| Dec 31, 2018 | 8.90% |
| Sep 30, 2018 | 3.37% |
| Jun 30, 2018 | -3.35% |
| Mar 31, 2018 | 9.13% |
| Dec 31, 2017 | 1.96% |
| Sep 30, 2017 | 4.85% |
| Jun 30, 2017 | 9.97% |
| Mar 31, 2017 | 4.68% |
| Dec 31, 2016 | 15.95% |
| Sep 30, 2016 | 9.35% |
| Jun 30, 2016 | 2.34% |
| Mar 31, 2016 | 10.41% |
| Dec 31, 2015 | 9.96% |
| Sep 30, 2015 | -14.72% |
| Jun 30, 2015 | 5.80% |
| Mar 31, 2015 | -7.77% |
| Dec 31, 2014 | 13.50% |
| Sep 30, 2014 | -3.64% |
| Jun 30, 2014 | 2.41% |
| Mar 31, 2014 | 1.75% |
| Dec 31, 2013 | 28.60% |
| Sep 30, 2013 | -10.15% |
| Jun 30, 2013 | 1.65% |
| Mar 31, 2013 | -6.36% |
| Dec 31, 2012 | 8.65% |
| Sep 30, 2012 | 8.14% |
| Jun 30, 2012 | -1.30% |
| Mar 31, 2012 | 6.95% |
| Dec 31, 2011 | 3.81% |
| Sep 30, 2011 | -3.90% |
| Jun 30, 2011 | 4.14% |
| Mar 31, 2011 | 11.53% |
| Dec 31, 2010 | 12.45% |
| Sep 30, 2010 | 14.63% |
| Jun 30, 2010 | 13.76% |
| Mar 31, 2010 | 13.11% |
| Dec 31, 2009 | 15.17% |
| Sep 30, 2009 | 13.83% |
| Jun 30, 2009 | 14.42% |